Back
Supernus Pharmaceuticals Stock Price Chart
Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
SUPN
Supernus Pharmaceuticals
Last Price:
$30.74
Seasonality Move:
13.42%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.4 | Sell |
| 20-day SMA: | 32.05 | Sell |
| 50-day SMA: | 33.6 | Sell |
| 200-day SMA: | 33.69 | Sell |
| 8-day EMA: | 31.45 | Sell |
| 20-day EMA: | 31.93 | Sell |
| 50-day EMA: | 33.18 | Sell |
| 200-day EMA: | 33.56 | Sell |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 39.99 | Sell |
| Chaikin Money Flow: | -300917 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.34 - 32.64) | Sell |
| Bollinger Bands (100): | (32.53 - 38.11) | Sell |
Supernus Pharmaceuticals Technical Analysis
| Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 30.71 while SUPN 8-day simple moving average is 31.40, which is a Sell signal.
-
The stock price of SUPN is 30.71 while Supernus Pharmaceuticals 20-day SMA is 32.05, which makes it a Sell.
-
Supernus Pharmaceuticals 50-day simple moving average is 33.60 while SUPN share price is 30.71, making it a Sell technically.
-
SUPN stock price is 30.71 and Supernus Pharmaceuticals 200-day simple moving average is 33.69, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a SellThe current Supernus Pharmaceuticals [SUPN] share price is $30.71. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.7B
Price in USD:
30.71
Share Volume:
357.8K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
25.53
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 30.71 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 30.71 while SUPN 8-day exponential moving average is 31.45, which is a Sell signal.
-
The stock price of SUPN is 30.71 while Supernus Pharmaceuticals 20-day EMA is 31.93, which makes it a Sell.
-
Supernus Pharmaceuticals 50-day exponential moving average is 33.18 while SUPN share price is 30.71, making it a Sell technically.
-
SUPN stock price is 30.71 and Supernus Pharmaceuticals 200-day simple moving average is 33.56, creating a Sell signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.91 per share, and an increase next year of $0.58 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is -0.57, suggesting Supernus Pharmaceuticals is a Sell
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 39.99, which suggest Supernus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (31.34 - 32.64), which suggest Supernus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (32.53 - 38.11), which suggest Supernus Pharmaceuticals is a Sell
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.